Group One Trading’s Bristol-Myers Squibb BMY Stock Holding History

Group One Trading’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.7M	Sell	275,500 -142,300	-34%	-$8.3M	0.03%	577
2025 Q4	$22.5M	Buy	417,800 +122,100	+41%	+$5.87M	0.04%	480
2025 Q3	$13.3M	Sell	295,700 -137,500	-32%	-$6.42M	0.02%	730
2025 Q2	$20.1M	Buy	433,200 +82,200	+23%	+$4.04M	0.04%	429
2025 Q1	$21.4M	Sell	351,000 -572,000	-62%	-$33.3M	0.06%	297
2024 Q4	$52.2M	Sell	923,000 -360,400	-28%	-$20.1M	0.12%	134
2024 Q3	$66.4M	Buy	1,283,400 +1,226,300	+2,148%	+$57.5M	0.19%	73
2024 Q2	$2.37M	Sell	57,100 -61,400	-52%	-$2.75M	0.01%	1303
2024 Q1	$6.43M	Sell	118,500 -154,100	-57%	-$7.85M	0.02%	671
2023 Q4	$14M	Buy	272,600 +24,800	+10%	+$1.3M	0.04%	502
2023 Q3	$14.4M	Sell	247,800 -118,500	-32%	-$7.26M	0.05%	343
2023 Q2	$23.4M	Buy	366,300 +32,800	+10%	+$2.2M	0.08%	195
2023 Q1	$23.1M	Sell	333,500 -276,400	-45%	-$19.5M	0.08%	183
2022 Q4	$43.9M	Sell	609,900 -125,100	-17%	-$9.43M	0.1%	171
2022 Q3	$52.3M	Sell	735,000 -327,700	-31%	-$23.8M	0.1%	128
2022 Q2	$81.8M	Sell	1,062,700 -37,300	-3%	-$2.84M	0.13%	96
2022 Q1	$80.3M	Sell	1,100,000 -85,500	-7%	-$5.74M	0.08%	151
2021 Q4	$73.9M	Buy	1,185,500 +198,000	+20%	+$11.6M	0.06%	213
2021 Q3	$58.4M	Buy	987,500 +191,400	+24%	+$12.6M	0.06%	247
2021 Q2	$53.2M	Sell	796,100 -177,300	-18%	-$11.6M	0.06%	240
2021 Q1	$61.5M	Buy	973,400 +292,000	+43%	+$18.2M	0.09%	165
2020 Q4	$42.3M	Sell	681,400 -175,300	-20%	-$10.8M	0.07%	227
2020 Q3	$51.6M	Buy	856,700 +5,000	+0.6%	+$301K	0.16%	95
2020 Q2	$50.1M	Buy	851,700 +112,600	+15%	+$6.73M	0.23%	67
2020 Q1	$41.2M	Buy	739,100 +174,700	+31%	+$10.7M	0.33%	43
2019 Q4	$36.2M	Sell	564,400 -178,800	-24%	-$10.2M	0.25%	56
2019 Q3	$37.7M	Sell	743,200 -52,900	-7%	-$2.49M	0.3%	38
2019 Q2	$36.1M	Sell	796,100 -48,000	-6%	-$2.24M	0.33%	35
2019 Q1	$40.3M	Buy	844,100 +609,900	+260%	+$30.4M	0.45%	23
2018 Q4	$12.2M	Buy	234,200 +95,300	+69%	+$5.12M	0.11%	190
2018 Q3	$8.62M	Sell	138,900 -404,300	-74%	-$24M	0.07%	327
2018 Q2	$30.1M	Sell	543,200 -87,600	-14%	-$4.73M	0.26%	55
2018 Q1	$39.9M	Sell	630,800 -123,200	-16%	-$7.93M	0.4%	24
2017 Q4	$46.2M	Buy	754,000 +107,200	+17%	+$6.71M	0.32%	46
2017 Q3	$41.2M	Sell	646,800 -37,100	-5%	-$2.17M	0.37%	31
2017 Q2	$38.1M	Sell	683,900 -338,300	-33%	-$18.4M	0.4%	29
2017 Q1	$55.6M	Buy	1,022,200 +854,100	+508%	+$46.8M	0.65%	11
2016 Q4	$9.82M	Buy	168,100 +4,400	+3%	+$241K	0.1%	227
2016 Q3	$8.83M	Buy	163,700 +57,700	+54%	+$3.71M	0.1%	218
2016 Q2	$7.8M	Buy	106,000 +27,100	+34%	+$1.91M	0.09%	237
2016 Q1	$5.04M	Sell	78,900 -167,100	-68%	-$10.5M	0.07%	337
2015 Q4	$16.9M	Buy	246,000 +6,700	+3%	+$443K	0.2%	73
2015 Q3	$14.2M	Buy	239,300 +119,200	+99%	+$7.56M	0.2%	90
2015 Q2	$7.99M	Sell	120,100 -43,800	-27%	-$2.89M	0.11%	189
2015 Q1	$10.6M	Buy	163,900 +150,100	+1,088%	+$9.4M	0.17%	99
2014 Q4	$815K	Buy	+13,800	New	+$778K	0.01%	1195

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's BMY Position: Q4 2025 in Review

Group One Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 27,906 shares — an estimated $1.34M sold.

Group One Trading first reported a position in BMY in Q3 2013 and held it in 35 quarters. The position peaked at $20.2M in Q1 2017. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Group One Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 27,906 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.34M.
Group One Trading first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 35 quarters.
Group One Trading's Bristol-Myers Squibb position peaked at $20.2M in Q1 2017.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.